HIGHLIGHTS
- who: August et al. from the University of Perugia, Italy have published the Article: Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behu00e7et s disease: A systematic review of controlled trials, in the Journal: (JOURNAL) of 17/Dec/2021
- how: Based on the above considerations the authors conducted a systematic review based on controlled trials to summarize the evidence of the efficacy and safety of anti-TNF-u03b1 therapy for all BD subtypes. Regarding the study population ten of thirteen studies were performed in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.